CTPA is Indicated Immediately
In an adult with acute dyspnea, pleuritic chest pain, tachycardia, hypoxia, and moderate-to-high suspicion for pulmonary embolism, CTPA should be performed directly without D-dimer testing, assuming no severe iodinated contrast allergy and acceptable renal function. 1, 2, 3
Algorithmic Approach Based on Pretest Probability
High Pretest Probability (Your Clinical Scenario)
- Proceed directly to CTPA 1, 2
- Do NOT obtain D-dimer testing first—this wastes time and will not change management 1
- CTPA is highly sensitive and specific for PE (>90%) 2, 4
- CTPA provides the additional benefit of identifying alternative diagnoses that may explain the patient's symptoms 2
The 2015 American College of Physicians guidelines explicitly state that clinicians should obtain CTPA imaging in patients with high pretest probability and should NOT obtain D-dimer measurements in this population 1. The 2022 ACR Appropriateness Criteria reinforces that CTPA is the first-line diagnostic imaging tool routinely performed for nearly all patients with high clinical suspicion 2. The most recent 2026 AHA/ACC multisociety guideline further supports this approach for acute PE evaluation 3.
Why Skip D-Dimer in High Probability Cases
The reasoning is straightforward:
- A negative D-dimer cannot adequately rule out PE when pretest probability is high (the post-test probability remains unacceptably elevated)
- A positive D-dimer (which is likely) adds no diagnostic value—you're getting imaging regardless
- Delaying imaging to obtain D-dimer only postpones definitive diagnosis and treatment 1
Clinical Context: Moderate-to-High Suspicion
Your patient presents with multiple classic PE features:
- Acute dyspnea (most common symptom)
- Pleuritic chest pain (suggests peripheral embolus with pleural irritation)
- Tachycardia (compensatory response)
- Hypoxia (indicates significant V/Q mismatch)
This constellation places the patient firmly in the moderate-to-high probability category where direct imaging is warranted.
CTPA Technical Considerations
Modern CTPA protocols offer:
- Diagnostic accuracy with contrast volumes as low as 20 mL in normal-weight patients 5
- Reduced radiation exposure with high-pitch techniques 5
- Excellent visualization from main pulmonary arteries to segmental branches 2
- Ability to detect alternative pathology (pneumonia, aortic dissection, pneumothorax) 2
Critical Pitfall to Avoid
Do not order "CT chest with contrast" instead of CTPA. The timing and technique of contrast administration differs significantly. CTPA requires specific bolus timing to opacify pulmonary arteries optimally. A standard chest CT with IV contrast will not adequately evaluate for PE 2.
When CTPA is Contraindicated
Reserve ventilation-perfusion (V/Q) scanning for:
- Severe iodinated contrast allergy (not your scenario)
- Significantly impaired renal function (not your scenario)
- CTPA unavailable 1
V/Q scanning has diminished in use due to high rates of nondiagnostic results and inability to provide alternative diagnoses 2.
Post-CTPA Management Note
If CTPA is negative in a patient with high clinical suspicion, this represents a diagnostic dilemma occurring in up to 40% of cases 6. However, outcome studies demonstrate that negative CTPA can safely rule out PE without additional imaging 4. The negative predictive value is sufficiently high that anticoagulation can be withheld 4.